Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Screening for testicular cancer: recommendation statement.

Calonge N; U.S. Preventive Services Task Force Agency for Healthcare Research and Quality.

Am Fam Physician. 2005 Nov 15;72(10):2069-70. No abstract available.

2.
3.

Enthusiasm for cancer screening in the United States.

Schwartz LM, Woloshin S, Fowler FJ Jr, Welch HG.

JAMA. 2004 Jan 7;291(1):71-8.

PMID:
14709578
4.

Effects of communicating individual risks in screening programmes: Cochrane systematic review.

Edwards A, Unigwe S, Elwyn G, Hood K.

BMJ. 2003 Sep 27;327(7417):703-9. Review.

5.

Decision aids for people facing health treatment or screening decisions.

O'Connor AM, Stacey D, Entwistle V, Llewellyn-Thomas H, Rovner D, Holmes-Rovner M, Tait V, Tetroe J, Fiset V, Barry M, Jones J.

Cochrane Database Syst Rev. 2003;(2):CD001431. Review. Update in: Cochrane Database Syst Rev. 2009;(3):CD001431.

PMID:
12804407
6.

Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented.

Raffle AE, Alden B, Quinn M, Babb PJ, Brett MT.

BMJ. 2003 Apr 26;326(7395):901. Erratum in: BMJ. 2003 Aug 9;327(7410):325.

7.

Detection of ductal carcinoma in situ in women undergoing screening mammography.

Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, Yankaskas BC, Rosenberg R, Carney PA, Kerlikowske K, Taplin SH, Urban N, Geller BM.

J Natl Cancer Inst. 2002 Oct 16;94(20):1546-54.

PMID:
12381707
8.

Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.

Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, Feuer EJ.

J Natl Cancer Inst. 2002 Jul 3;94(13):981-90.

PMID:
12096083
9.

Risk charts: putting cancer in context.

Woloshin S, Schwartz LM, Welch HG.

J Natl Cancer Inst. 2002 Jun 5;94(11):799-804. No abstract available.

PMID:
12048267
10.

Cochrane review on screening for breast cancer with mammography.

Olsen O, G√łtzsche PC.

Lancet. 2001 Oct 20;358(9290):1340-2. Erratum in: Lancet. 2006 Feb 11;367(9509):474.

PMID:
11684218
11.

Increasing informed uptake and non-uptake of screening: evidence from a systematic review.

Jepson RG, Forbes CA, Sowden AJ, Lewis RA.

Health Expect. 2001 Jun;4(2):116-26. Review. Erratum in: Health Expect 2001 Dec;4(4):270.

12.
13.
14.

A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial.

Man-Son-Hing M, Laupacis A, O'Connor AM, Biggs J, Drake E, Yetisir E, Hart RG.

JAMA. 1999 Aug 25;282(8):737-43.

PMID:
10463708
15.

Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group.

Barratt A, Irwig L, Glasziou P, Cumming RG, Raffle A, Hicks N, Gray JA, Guyatt GH.

JAMA. 1999 Jun 2;281(21):2029-34. No abstract available.

PMID:
10359392
16.

A systematic review of the use of computers in the management of hypertension.

Montgomery AA, Fahey T.

J Epidemiol Community Health. 1998 Aug;52(8):520-5.

17.

A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult.

Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C.

BMJ. 1998 Aug 29;317(7158):559-65.

18.

Ten-year risk of false positive screening mammograms and clinical breast examinations.

Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW.

N Engl J Med. 1998 Apr 16;338(16):1089-96.

19.

Distressed or relieved? Psychological side effects of breast cancer screening in The Netherlands.

Scaf-Klomp W, Sanderman R, van de Wiel HB, Otter R, van den Heuvel WJ.

J Epidemiol Community Health. 1997 Dec;51(6):705-10.

20.

Supplemental Content

Support Center